Insufficient scRNA-seq data for expression of SLFN12 at single-cell level.
Insufficient scRNA-seq data for expression of SLFN12 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 511.22 | 653 / 653 | 94% | 7.28 | 569 / 605 |
ovary | 100% | 345.26 | 180 / 180 | 90% | 5.13 | 388 / 430 |
lung | 100% | 497.06 | 578 / 578 | 86% | 5.84 | 990 / 1155 |
breast | 100% | 452.70 | 459 / 459 | 85% | 6.20 | 945 / 1118 |
kidney | 99% | 224.30 | 88 / 89 | 84% | 6.83 | 760 / 901 |
esophagus | 98% | 242.41 | 1416 / 1445 | 79% | 5.11 | 145 / 183 |
uterus | 99% | 355.78 | 169 / 170 | 73% | 4.29 | 337 / 459 |
skin | 90% | 390.09 | 1632 / 1809 | 79% | 6.82 | 373 / 472 |
bladder | 100% | 250.95 | 21 / 21 | 58% | 3.60 | 292 / 504 |
pancreas | 66% | 81.03 | 217 / 328 | 86% | 4.73 | 153 / 178 |
stomach | 94% | 190.82 | 339 / 359 | 57% | 2.87 | 162 / 286 |
adrenal gland | 100% | 499.17 | 257 / 258 | 35% | 1.36 | 81 / 230 |
intestine | 99% | 300.05 | 957 / 966 | 36% | 1.59 | 188 / 527 |
prostate | 98% | 250.06 | 241 / 245 | 29% | 0.94 | 147 / 502 |
spleen | 100% | 698.55 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 469.81 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 316.49 | 1314 / 1335 | 0% | 0 | 0 / 0 |
heart | 95% | 181.45 | 821 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 87% | 381.58 | 805 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 78% | 3.12 | 35 / 45 |
lymph node | 0% | 0 | 0 / 0 | 72% | 3.75 | 21 / 29 |
brain | 29% | 30.06 | 757 / 2642 | 42% | 2.02 | 298 / 705 |
eye | 0% | 0 | 0 / 0 | 61% | 3.02 | 49 / 80 |
liver | 34% | 33.98 | 76 / 226 | 24% | 1.37 | 99 / 406 |
muscle | 27% | 26.03 | 217 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097190 | Biological process | apoptotic signaling pathway |
GO_0016075 | Biological process | rRNA catabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0043022 | Molecular function | ribosome binding |
GO_0005515 | Molecular function | protein binding |
GO_0004540 | Molecular function | RNA nuclease activity |
Gene name | SLFN12 |
Protein name | Ribonuclease SLFN12 (EC 3.1.-.-) (Schlafen family member 12) Schlafen family member 12 |
Synonyms | |
Description | FUNCTION: Ribonuclease which is part of an E2/17beta-estradiol-induced pro-apoptotic signaling pathway. E2 stabilizes the PDE3A/SLFN12 complex in the cytosol, promoting the dephosphorylation of SLFN12 and activating its pro-apoptotic ribosomal RNA/rRNA ribonuclease activity. This apoptotic pathway might be relevant in tissues with high concentration of E2 and be for instance involved in placenta remodeling . May play a role in cell differentiation . . |
Accessions | ENST00000452764.3 Q8IYM2 ENST00000447040.6 ENST00000445092.5 ENST00000304905.10 ENST00000394562.5 C9JIA1 C9J4K7 |